U.S. Colorectal Cancer Screening Market GRÖSSEN- UND MARKTANTEILSANALYSE - WACHSTUMSTRENDS UND PROGNOSEN (2024 - 2031)
U.S. Colorectal Cancer Screening Market is Segmented By Test Type (Fecal Immunochemical Test (FIT), Guaiac-based Fecal Occult Blood Test, Stool DNA Test, and Others), By Imaging Type (Sigmoidoscopy, Colonoscopy, Virtual Colonoscopy, and Others), By End User (Hospitals, Diagnostic Laboratories, Academic and Research Institutes, and Others). The report offers the value (in USD billion) for the above-mentioned segments.
Competitive overview of U.S. Colorectal Cancer Screening Market
Major Players, die auf dem US-amerikanischen Dickdarmkrebs-Screening-Markt tätig sind, sind Polymedco Inc., Eiken Chemical Co. Ltd., Sysmex Corporation, Quidel Corporation, Novigenix SA, Hemosure Inc., Exact Sciences Corp., Epigenomics Inc., Olympus Corporation, Clinical Genomics Technologies Pty Ltd., Abbott, F. Hoffmann-La Roche PhilipA, Siemens Healthineers, Koninklijk.
U.S. Colorectal Cancer Screening Market Leaders
- Polymedco Inc.
- Eiken Chemical Co. Ltd.
- Sysmex Corporation
- Quidel Corporation
- Novigenix SA
U.S. Colorectal Cancer Screening Market - Competitive Rivalry, 2023
U.S. Colorectal Cancer Screening Market
(Dominated by major players)
(Highly competitive with lots of players.)